Real World Insights

Providing Pharma & Biopharma with RWD & AI-Driven Insights on Patient Populations Affected by Speciality & Rare Diseases

Using ML/AI to Find the Right Patients at the Right Time: A Conversation with AVEO Oncology

By: John Seaner, CMO, IPM.ai/Swoop

Ganesh Rajaratnam, Senior Director of Commercial Operations, Insights & Analytics at AVEO Oncology spoke with IPM.ai’s Senior Vice President, Andrea Lacianca and Associate Principal Ivan Kouchlev, to discuss patient finding at key intervals of the treatment journey.  

IPM.ai Recognized as One of the World’s Most Innovative Companies in 2022 by Fast Company

IPM.ai’s transformative approach to patient-finding for specialty and rare conditions captures the...

Ron Elwell, CEO and Founder of IPM.ai Wins MM+M’s Pinnacle Award

By: John Seaner, CMO, IPM.ai/Swoop

Ron Elwell, CEO and founder of IPM.ai is a proud recipient of ...

Utilizing Augmented Intelligence to Drive Optimal Decisions Throughout the Specialty and Rare Disease Product Lifecycle

By: John Seaner, CMO, IPM.ai/Swoop

Life sciences and healthcare companies that set out to pioneer...

Building a Rare Disease Franchise with Machine Learning and Artificial Intelligence

By: John Seaner, CMO, IPM.ai/Swoop

Nitin Choudhary, Managing Principal of IPM.ai and Richard...

A New Reference Model for Clinical Study Recruitment

By: John Seaner, CMO, IPM.ai/Swoop

Conventional clinical study recruitment methods for rare...

Real Chemistry's IPM.ai Expands Partnership with Datavant

San Francisco – Aug. 19, 2021 – Real Chemistry’s IPM.ai, the leader in uncovering undiagnosed and...

IPM.ai's Clinical Trial Recruitment Solution Featured in MM&M

By: John Seaner, CMO, IPM.ai/Swoop

Allison Rhee of MM&M reports on IPM.ai's answer to patient...

Kyowa Kirin Uses AI/ML to Uncover Undiagnosed Patients

By: John Seaner, CMO, IPM.ai/Swoop

The rare disease patient journey can be arduous. Many patients...

IPM.ai Accelerates the Clinical Study and Commercialization of Precision Medicine

Targeted Approach Optimizes Clinical Study Recruitment of Medically-Eligible Patients Affected by...